Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

This study has been completed.

Sponsor:

Collaborator:

Deutsche Krebshilfe e.V., Bonn (Germany)

Information provided by (Responsible Party):

Bogdana Suchorska, Ludwig-Maximilians - University of Munich

ClinicalTrials.gov Identifier:

NCT01089868

First received: March 17, 2010

Last updated: August 5, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2012
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)